Angelini Pharma
Angelini Pharma is a healthcare company that focuses on the development and commercialization of innovative products in mental health, pain and inflammation, and pediatrics. The organization aims to address significant medical needs by providing effective solutions and therapies that enhance patient care. With a commitment to improving health outcomes, Angelini Pharma leverages its expertise to deliver targeted treatments and support for various health conditions.
Top Stages
2 past transactions
Arvelle Therapeutics
Acquisition in 2021
Arvelle Therapeutics GmbH is a biopharmaceutical company based in Zug, Switzerland, founded in 2019. The company focuses on developing and commercializing innovative treatments for patients with central nervous system (CNS) disorders. Its primary product is cenobamate, an investigational antiepileptic drug aimed at providing effective solutions for patients suffering from focal seizures. By targeting debilitating neurological and neuromuscular diseases, Arvelle Therapeutics aims to enhance the quality of care available to clinicians and their patients.
GRIN Therapeutics
GRIN Therapeutics is a clinical-stage biotechnology company dedicated to developing precision therapeutics for serious pediatric neurodevelopmental disorders.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.